Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1497 |  ADPT Adaptive Biotechnologies Corporation - Common Stock | 25.35 USD | -2.46% | +1.52% | +11.58% | +46.87% | 4.05 B USD | ||
| 1517 |  LEGN Legend Biotech Corporation - American Depositary Shares | 21.01 USD | -3.71% | +3.29% | +2.24% | -34.30% | 3.89 B USD | ||
| 1519 |  TNGX Tango Therapeutics, Inc. - Common Stock | 23.16 USD | -3.02% | -9.57% | -13.52% | +238.10% | 3.91 B USD | ||
| 1522 |  DNLI Denali Therapeutics Inc. - Common Stock | 23.75 USD | -4.70% | -2.22% | +0.68% | +46.88% | 3.80 B USD | ||
| 1531 |  VKTX Viking Therapeutics, Inc. - Common Stock | 32.94 USD | -2.80% | -0.18% | -6.98% | +27.62% | 3.84 B USD | ||
| 1549 |  RCUS Arcus Biosciences, Inc. Common Stock | 29.71 USD | -2.11% | +0.20% | +3.23% | +181.08% | 3.78 B USD | ||
| 1554 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.62 USD | +2.56% | -0.77% | +14.60% | +84.15% | 3.94 B USD | ||
| 1556 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 39.29 USD | -0.96% | +8.12% | +8.06% | +20.60% | 3.79 B USD | ||
| 1565 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 7.89 USD | -4.83% | +15.86% | +57.17% | +207.00% | 3.57 B USD | ||
| 1614 |  GPCR Structure Therapeutics Inc - American Depositary Shares | 47.99 USD | -2.24% | -11.88% | -2.76% | +79.47% | 3.42 B USD | ||
| 1618 |  ABCL AbCellera Biologics Inc. - Common Shares | 10.76 USD | -4.95% | -2.00% | +100.00% | +147.36% | 3.30 B USD | ||
| 1635 |  VCYT Veracyte, Inc. - Common Stock | 41.25 USD | -2.51% | -1.01% | -28.61% | +11.79% | 3.32 B USD | ||
| 1650 |  QURE uniQure N.V. - Ordinary Shares | 46.80 USD | -3.25% | -1.74% | +21.56% | +199.23% | 3.25 B USD | ||
| 1655 |  NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 26.90 USD | -3.48% | +0.79% | -10.66% | -25.83% | 3.22 B USD | ||
| 1673 |  IMNM Immunome, Inc. - Common Stock | 27.89 USD | -2.21% | +3.33% | +23.46% | +168.69% | 3.17 B USD | ||
| 1688 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 71.77 USD | -1.28% | +3.56% | +22.18% | +8.64% | 3.15 B USD | ||
| 1695 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 39.93 USD | -1.11% | -5.18% | +11.91% | +46.59% | 3.14 B USD | ||
| 1701 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 24.78 USD | -1.20% | -4.98% | -10.28% | +54.88% | 3.11 B USD | ||
| 1706 |  ALMS Alumis Inc. - Common Stock | 22.95 USD | -5.05% | -8.35% | -17.42% | +408.87% | 2.97 B USD | ||
| 1707 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 14.28 USD | -7.63% | +14.15% | +26.82% | +647.64% | 2.88 B USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
 ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |